TechFlow news, on August 23, according to Strategic ETH Reserve's post on X, Nasdaq-listed Ethereum treasury company ETHZilla (formerly 180 Life Sciences Corp.) disclosed that it has revised its previously signed securities sales agreement, involving the issuance of common stock in a prospectus supplement and accompanying prospectus. Under the revised agreement terms, the company may raise up to $10,000,000,000 through the issuance and sale of shares of common stock to support its continued purchase of ETH.
Add to Favorites
Share to Social Media
